# D4D Datasheet for CM4AI Dataset
# Generation Method: Claude Code Assistant Interactive
# Source: data/preprocessed/concatenated/CM4AI_preprocessed.txt (122K, 6 source files)
# Schema: src/data_sheets_schema/schema/data_sheets_schema_all.yaml
# Generated: 2025-12-20

id: https://doi.org/10.18130/V3/DXWOS5
name: CM4AI
title: Cell Maps for Artificial Intelligence (CM4AI)
description: >
  CM4AI is the Functional Genomics Data Generation Project in the U.S. National Institutes of Health's
  (NIH) Bridge to Artificial Intelligence (Bridge2AI) program. Its overarching mission is to produce
  ethical, AI-ready datasets of cell architecture, inferred from multimodal data collected for human
  cell lines, to enable transformative biomedical AI research. The project delivers machine-readable
  hierarchical maps of cell architecture as AI-Ready data produced from multimodal interrogation of
  100 chromatin modifiers and 100 metabolic enzymes involved in cancer, neuropsychiatric, and cardiac
  disorders in disease-relevant cell lines under perturbed and unperturbed conditions. Data streams
  include immunofluorescence (IF) subcellular microscopy for spatial proteomics, affinity purification
  mass spectroscopy (AP-MS) and size exclusion mass spectroscopy (SEC-MS) for protein-protein
  interaction (PPI) data, and single-cell CRISPR-Cas perturbation screens by cell type. Input data
  streams are integrated via the Multi-Scale Integrated Cell (MuSIC) software pipeline employing deep
  learning models and community detection algorithms, and output cell maps are packaged with provenance
  graphs and rich metadata as AI-Ready datasets in RO-Crate format using the FAIRSCAPE framework.
page: https://www.cm4ai.org
language: en
keywords:
  - Cell Maps
  - Artificial Intelligence
  - AI-Ready Data
  - Bridge2AI
  - Functional Genomics
  - Protein-Protein Interactions
  - Spatial Proteomics
  - CRISPR Perturbation
  - Hierarchical Cell Maps
  - MDA-MB-468
  - KOLF2.1J
  - iPSC
  - Breast Cancer
  - Chromatin Modifiers
  - Metabolic Enzymes
  - Immunofluorescence
  - Mass Spectrometry
  - AP-MS
  - SEC-MS
  - Perturb-Seq
  - FAIR Principles
  - RO-Crate
  - FAIRSCAPE
  - Visible Neural Networks
  - Deep Learning
  - MuSIC Pipeline

# Motivation
purposes:
  - id: purpose-001
    description: >
      Deliver machine-readable hierarchical maps of cell architecture as AI-Ready data from multimodal
      interrogation of disease-relevant cell lines to enable transformative biomedical AI research.
      CM4AI produces integrated cell maps from spatial proteomics, protein-protein interactions, and
      genetic perturbations using state-of-the-art mass spectrometry, cell imaging, and CRISPR
      technologies.
  - id: purpose-002
    description: >
      Address the grand challenge of interpretable genotype-phenotype learning in genomics and
      precision medicine. Machine learning models are often black boxes predicting phenotypes from
      genotypes without understanding the mechanisms. CM4AI enables visible machine learning systems
      informed by multi-scale cell and tissue architecture, allowing AI tools to interrogate how
      protein assemblies in the cell affect cell-level phenotype predictions.
  - id: purpose-003
    description: >
      Establish standards, best practices, and guidelines for ethical AI-readiness in biomedical data.
      This includes implementing FAIR principles, computing machine-readable provenance graphs,
      characterizing and validating all datasets with JSON-Schema mini-data-dictionaries, and mapping
      data elements to public ontology vocabularies where appropriate.
  - id: purpose-004
    description: >
      Enable development of visible neural networks (VNNs) and visible machine learning tools that
      use hierarchical cell maps as interpretable structures for AI model architectures, allowing
      interrogation of how protein assemblies affect cell-level phenotypes and interpretation of
      genetic variants and mutations.

tasks:
  - id: task-001
    description: >
      Multi-Scale Cell Mapping via MuSIC Pipeline: Integrate multimodal data streams (spatial proteomics
      via IF imaging, protein-protein interactions via AP-MS and SEC-MS, and genetic perturbations via
      CRISPR screens) using the Multi-Scale Integrated Cell (MuSIC) software pipeline employing deep
      learning models and community detection algorithms to produce hierarchical cell maps.
  - id: task-002
    description: >
      Disease-Relevant Cell Line Characterization: Characterize cell architecture and protein interactions
      in disease-relevant cell lines including treated and untreated MDA-MB-468 breast cancer cells (with
      paclitaxel and vorinostat) and differentiated and naive KOLF2.1J induced pluripotent stem cells
      (iPSCs) differentiated into neurons and cardiomyocytes.
  - id: task-003
    description: >
      Ethical AI Framework Development: Develop ethical AI frameworks and governance structures for
      biomedical data, including Value-Sensitive Design methodologies, axiological repositories, CM4AI
      Life Cycle framework, and guidelines for responsible design of datasets and AI technologies.
  - id: task-004
    description: >
      Skills and Workforce Development: Recruit and train a diverse biomedical AI/ML workforce through
      asynchronous virtual training, hosted virtual events (CodeFest), and in-person internships at
      Yale University and UC San Diego, with emphasis on underrepresented communities through partnerships
      with historically black colleges and universities.

addressing_gaps:
  - id: gap-001
    description: >
      Address the limitation that machine learning models in genomics and precision medicine are
      typically difficult-to-interpret black boxes by providing hierarchical cell maps that enable
      visible machine learning systems built directly on knowledge maps of cell and tissue architecture.
  - id: gap-002
    description: >
      Provide fully provenanced, ethically validated, and FAIR-compliant AI-ready datasets with
      machine-readable provenance graphs, complete schemas, validation procedures, and data sheets
      that can be reliably processed by AI applications with full explainability.
  - id: gap-003
    description: >
      Create integrated datasets combining protein localization (spatial proteomics), protein-protein
      interactions (AP-MS and SEC-MS), and transcriptional states (CRISPR perturbation screens) at
      multiple scales, enabling complex multi-modal AI analyses not feasible with single data types.

# Creators and Contributors
creators:
  - id: creator-001
    description: Trey Ideker - Contact PI/Project Leader, University of California San Diego, Department of Internal Medicine/Medicine, ORCID 0000-0002-1708-8454
  - id: creator-002
    description: Jean-Christophe BÃ©lisle-Pipon - Co-Investigator, Simon Fraser University, Ethics Module Leader, ORCID 0000-0002-8965-8153
  - id: creator-003
    description: Timothy Clark - Co-Investigator, University of Virginia, Standards Module, ORCID 0000-0003-4060-7360
  - id: creator-004
    description: Jake Yue Chen - Co-Investigator, University of Alabama at Birmingham, Teaming Module, ORCID 0000-0002-6112-415X
  - id: creator-005
    description: Nevan J Krogan - Co-Investigator, University of California San Francisco, Data Acquisition Module (Protein-Protein Interactions), ORCID 0000-0003-4902-337X
  - id: creator-006
    description: Emma Lundberg - Co-Investigator, Stanford University, Data Acquisition Module (Spatial Proteomics), ORCID 0000-0001-7034-0850
  - id: creator-007
    description: Prashant Mali - Co-Investigator, University of California San Diego, Data Acquisition Module (Genetic Perturbations), ORCID 0000-0002-3383-1287
  - id: creator-008
    description: Sarah J Ratcliffe - Co-Investigator, University of Virginia, ORCID 0000-0002-6644-8284
  - id: creator-009
    description: Vardit Ravitsky - Co-Investigator, University of Montreal, Ethics Module, ORCID 0000-0002-7080-8801
  - id: creator-010
    description: Andrej Sali - Co-Investigator, University of California San Francisco, Integrative Structure Modeling, ORCID 0000-0003-0435-6197
  - id: creator-011
    description: Wade Loren Schulz - Co-Investigator, Yale University, Skills and Workforce Development Module, ORCID 0000-0002-2048-4028
  - id: creator-012
    description: Ying Ding - Co-Investigator, University of Texas at Austin, ORCID 0000-0003-2567-2009
  - id: creator-013
    description: Samah Fodeh - Co-Investigator, Yale University, ORCID 0000-0003-4664-3143
  - id: creator-014
    description: Cynthia Brandt - Co-Investigator, Yale University, ORCID 0000-0001-8179-1796
  - id: creator-015
    description: Pamela Payne-Foster - Co-Investigator, University of Alabama, ORCID 0000-0002-3508-3577

funders:
  - id: funder-001
    description: >
      NIH Common Fund Bridge2AI Program funded through National Institutes of Health grant
      1OT2OD032742-01 (Bridge2AI Functional Genomics) and 5U54HG012513-02 (Bridge2AI Bridge Center),
      administered by NIH Office of the Director. Opportunity Number OTA-21-008. Project dates:
      September 1, 2022 to August 31, 2026. FY 2025 funding: $5,289,382 (Direct: $4,632,095,
      Indirect: $657,287). Additional funding from the Frederick Thomas Fund of the University of Virginia.

# Composition
instances:
  - id: instance-001
    description: >
      MDA-MB-468 Breast Cancer Cell Line (RRID:CVCL_0419): Triple negative breast cancer cell line
      established from a metastatic site pleural effusion of a 51-year-old black female with a
      metastatic mammary adenocarcinoma, available from ATCC. This cell line has been extensively
      used to study triple-negative breast cancer and is well characterized with transcriptomic,
      mutational profile, and whole-genome sequencing data available. Cells are analyzed under three
      conditions: untreated, paclitaxel-treated, and vorinostat-treated. Cultured cell line from
      de-identified human tissue, ethically sourced from ATCC.
  - id: instance-002
    description: >
      KOLF2.1J Induced Pluripotent Stem Cells (RRID:CVCL_B5P3): Human induced pluripotent stem cell
      (iPSC) line derived from a healthy male Northern European donor, available from the Human
      Induced Pluripotent Stem Cells Initiative (HipSci) resource. Available for access by non-for-profit
      organizations via a simple MTA. Analyzed in undifferentiated state and after differentiation into
      neurons, neural progenitor cells (NPCs), and cardiomyocytes. Cultured cell line from de-identified
      human tissue, ethically sourced from HipSci.
  - id: instance-003
    description: >
      100 Chromatin Regulators: Near-comprehensive set of chromatin regulators encoded by the human
      genome analyzed via AP-MS, SEC-MS, IF imaging, and CRISPR perturbation screens across different
      cell states and treatment conditions. 17 genes endogenously tagged in MDA-MB-468 with AP-MS data
      under three conditions, with 34 additional genes in process. SEC-MS identified 72/100 chromatin
      modifiers, with 52 being integral components of protein complexes. Protein targets for multi-modal
      analysis.
  - id: instance-004
    description: >
      100 Metabolic Enzymes: Set of metabolic enzymes involved in cancer, neuropsychiatric, and cardiac
      disorders analyzed via multimodal interrogation including mass spectrometry, imaging, and
      perturbation screens. Protein targets for multi-modal analysis.

subsets:
  - id: subset-001
    description: >
      Spatial Proteomics IF Images - MDA-MB-468: Immunofluorescence-based staining (ICC-IF) and confocal
      microscopy images displaying spatial localization of 464-563 proteins of interest in MDA-MB-468
      breast cancer cells under three conditions: untreated, paclitaxel-treated, and vorinostat-treated.
      Nuclei stained with DAPI (blue channel), endoplasmic reticulum with calreticulin antibody (yellow
      channel), microtubules with tubulin antibody (red channel), and antibody against protein of
      interest (green channel). Generated by Lundberg Lab at Stanford University using automated fixation
      and permeabilization protocols. Data released as ZIP archives (2.6-4.6 GB per condition) via
      University of Virginia Dataverse.
  - id: subset-002
    description: >
      Protein-Protein Interaction AP-MS Data: Affinity purification mass spectrometry (AP-MS) data on
      endogenously tagged cell lines mapping protein-protein interactions of chromatin regulators.
      17 genes endogenously tagged in MDA-MB-468 with data acquired under three conditions (untreated,
      paclitaxel, vorinostat). 34 additional genes currently in tagging process. Orthogonal approach to
      SEC-MS for PPI mapping. Data deposited to MassIVE Repository for human cancer cells.
  - id: subset-003
    description: >
      Protein-Protein Interaction SEC-MS Data: Size exclusion chromatography coupled to mass spectrometry
      (SEC-MS) for proteome-wide complex/interaction mapping. Performed on MDA-MB-468 cells under three
      conditions (untreated, paclitaxel, vorinostat) and on KOLF2.1J iPSCs and derivatives (undifferentiated,
      neurons, NPCs, cardiomyocytes). Detected PPI profiles of over 1,000 complexes in MDA-MB-468 cells
      and over 700 protein complexes in iPSCs and differentiated neurons. Identified 72/100 chromatin
      modifiers with 52 being integral components of protein complexes. Data deposited to MassIVE
      Repository for human iPSCs and cancer cells.
  - id: subset-004
    description: >
      CRISPR Perturbation Cell Atlas: Genome-scale CRISPRi perturbation cell atlas in undifferentiated
      KOLF2.1J human induced pluripotent stem cells (hiPSCs) mapping transcriptional and fitness phenotypes
      associated with 11,739 targeted genes. Single-cell CRISPR screens performed using 10x Genomics 3'HT
      kit with CRISPR lentiviral library targeting 100 chromatin factors with 6 guide RNAs per gene.
      Screens conducted in MDA-MB-468 cells under 3 conditions (no treatment, paclitaxel, vorinostat) and
      KOLF2.1J iPSC in undifferentiated state. Includes raw sequence data deposited to NCBI BioProject/
      Sequence Read Archive (SRA) and processed cell atlas data in RO-Crate format.
  - id: subset-005
    description: >
      Hierarchical Cell Maps via MuSIC: Integrated hierarchical cell maps produced by Multi-Scale Integrated
      Cell (MuSIC) pipeline from fusion of protein localization (IF images) and protein-protein interaction
      data (AP-MS and SEC-MS). Cell maps are hierarchical directed acyclic graphs (DAG) where each node
      represents an assembly of proteins in proximity at a given scale, spanning from large assemblies
      representing cell compartments to small assemblies of protein complexes. Maps contain 10 layers of
      depth representing communities at multiple resolutions, with communities at smaller distance nested
      inside larger communities similar to physical compartments within a cell. Not included in current
      interim releases but planned for future data releases.

sampling_strategies:
  - id: sampling-001
    description: >
      Disease-Relevant Cell Line Selection: Purposive selection of two disease-relevant cell lines:
      MDA-MB-468 triple negative breast cancer cell line for cancer research, and KOLF2.1J iPSCs for
      neuropsychiatric and cardiac disorder research. Both cell lines ethically sourced and well-characterized
      in the literature. MDA-MB-468 chosen for triple-negative breast cancer research applications.
      KOLF2.1J chosen as reference iPSC line for large-scale collaborative studies. Both cell lines have
      extensive existing characterization data. Not a representative sample of all biological variants.

subpopulations:
  - id: subpop-001
    description: MDA-MB-468 Untreated - MDA-MB-468 breast cancer cells in control/untreated condition
  - id: subpop-002
    description: MDA-MB-468 Paclitaxel-Treated - MDA-MB-468 breast cancer cells treated with paclitaxel chemotherapy
  - id: subpop-003
    description: MDA-MB-468 Vorinostat-Treated - MDA-MB-468 breast cancer cells treated with vorinostat chemotherapy
  - id: subpop-004
    description: KOLF2.1J Undifferentiated iPSCs - KOLF2.1J induced pluripotent stem cells in undifferentiated/naive state
  - id: subpop-005
    description: KOLF2.1J iPSC-Derived Neurons - KOLF2.1J iPSCs differentiated into neurons
  - id: subpop-006
    description: KOLF2.1J iPSC-Derived Neural Progenitor Cells (NPCs) - KOLF2.1J iPSCs differentiated into neural progenitor cells
  - id: subpop-007
    description: KOLF2.1J iPSC-Derived Cardiomyocytes - KOLF2.1J iPSCs differentiated into cardiomyocytes

# Collection Process
collection_mechanisms:
  - id: collection-001
    description: >
      Immunofluorescence Spatial Proteomics Imaging: Automated fixation and permeabilization protocols
      using pipetting robot for MDA-MB-468 and KOLF2.1J cell lines. Immunofluorescence-based staining
      (ICC-IF) with confocal microscopy to capture spatial subcellular organization. Completed spatial
      proteomics mapping of 100 chromatin regulators in MDA-MB-468 cells under three conditions (untreated,
      paclitaxel, vorinostat), with 500 additional proteins pending from genetic perturbations and PPI
      results. Antibodies from Human Protein Atlas resource. Generated by Lundberg Lab at Stanford University.
  - id: collection-002
    description: >
      Affinity Purification Mass Spectrometry: Endogenous tagging of genes in cell lines followed by
      affinity purification mass spectrometry (AP-MS) to map protein-protein interactions. 17 genes
      endogenously tagged in MDA-MB-468 with AP-MS data acquired under three conditions (untreated,
      paclitaxel, vorinostat). 34 additional genes currently in tagging process. Orthogonal approach to
      SEC-MS for comprehensive PPI mapping. Generated by Krogan Laboratory at UCSF.
  - id: collection-003
    description: >
      Size Exclusion Chromatography Mass Spectrometry: Size exclusion chromatography coupled to mass
      spectrometry (SEC-MS) for proteome-wide complex/interaction mapping. Performed in Krogan Laboratory
      at UCSF. Conducted on MDA-MB-468 cells under three conditions and on KOLF2.1J iPSCs and derivatives
      (undifferentiated, NPCs, neurons, cardiomyocytes). Enabled detection of over 1,000 protein complexes
      in MDA-MB-468 cells and over 700 complexes in iPSCs, with thousands of proteins exhibiting
      differential elution profiles between control and treated cells.
  - id: collection-004
    description: >
      CRISPR Perturbation Screens: Single-cell CRISPR screens using CRISPR lentiviral library targeting
      100 chromatin factors with 6 guide RNAs per gene. Generated and characterized MDA-MB-468 and KOLF2.1J
      CRISPR lines expressing inducible dCas9. Screens performed in MDA-MB-468 cells under 3 conditions
      (no treatment, paclitaxel, vorinostat) and in undifferentiated KOLF2.1J iPSCs using 10x Genomics
      3'HT kit. Genome-scale screens mapping transcriptional and fitness phenotypes for 11,739 targeted
      genes. Generated by Mali Laboratory at UC San Diego.

acquisition_methods:
  - id: acquisition-001
    description: >
      Confocal Microscopy for Subcellular Imaging: High-resolution confocal microscopy of immunofluorescence-stained
      cells capturing four channels: DAPI (nuclei, blue), calreticulin antibody (ER, yellow), tubulin
      antibody (microtubules, red), and antibody against protein of interest (green). Images processed
      using Human Protein Atlas deep learning model to reduce dimensionality, producing image embeddings
      containing information about protein localization.
  - id: acquisition-002
    description: >
      Mass Spectrometry for Protein Interactions: State-of-the-art mass spectrometry-based proteomics
      including AP-MS on endogenously tagged cell lines and SEC-MS for proteome-wide complex mapping.
      PPI networks processed using node2vec deep learning model to reduce dimensionality, producing PPI
      embeddings containing information about protein interactions.
  - id: acquisition-003
    description: >
      Single-Cell RNA Sequencing for Perturbation Mapping: Single-cell RNA sequencing using 10x Genomics
      3'HT kit to capture transcriptional states following CRISPR perturbations. Generates genome-scale
      perturbation cell atlas mapping transcriptional and fitness phenotypes. Raw sequence data deposited
      to NCBI BioProject/Sequence Read Archive (SRA).
  - id: acquisition-004
    description: >
      MuSIC Pipeline Integration: Multi-Scale Integrated Cell (MuSIC) pipeline integrates PPI embeddings
      and image embeddings using contrastive deep learning to obtain co-embeddings for each protein.
      Community detection performed based on all-by-all similarities of protein pairs in co-embedding
      space, producing hierarchical cell maps as final output. Maps annotated using Gene Ontology,
      Reactome pathways, and large language model approaches.

# Preprocessing, Cleaning, and Labeling
preprocessing_strategies:
  - id: preproc-001
    description: >
      Deep Learning Embedding Generation: PPI networks processed using node2vec deep learning model to
      reduce dimensionality and produce PPI embeddings. IF images processed using Human Protein Atlas
      deep learning model to reduce dimensionality and produce image embeddings. PPI and image embeddings
      integrated to obtain co-embeddings using contrastive deep learning, learning co-embeddings such
      that original embeddings can be reconstructed with minimal information loss.
  - id: preproc-002
    description: >
      Hierarchical Community Detection: Community detection performed on co-embedding space using multiscale
      community detection algorithms implemented in Cytoscape. Produces hierarchical directed acyclic
      graphs (DAG) of protein assemblies at multiple resolutions, with 10 layers of depth representing
      communities from large cell compartments to small protein complexes.
  - id: preproc-003
    description: >
      Cell Map Annotation: Two-pronged annotation approach: (1) Alignment to known protein function and
      pathway resources including Gene Ontology (GO) and Reactome to determine protein assemblies with
      high overlap with known cell biology, and (2) Large language model (LLM) approach to name sets of
      proteins and assign name confidence scores.
  - id: preproc-004
    description: >
      Quality Control for Imaging Data: Standardized automated fixation and permeabilization protocols
      using pipetting robot. Consistent staining protocols across conditions using Human Protein Atlas
      antibodies. Quality control of imaging data before release and processing through MuSIC pipeline.
  - id: preproc-005
    description: >
      Quality Control for Mass Spectrometry Data: Quality control and validation of AP-MS and SEC-MS data.
      Data currently undergoing quality checks before public release. Mass spectrometry data for human
      iPSCs deposited to MassIVE Repository, and data for human cancer cells also deposited to MassIVE
      Repository.

cleaning_strategies:
  - id: cleaning-001
    description: >
      FAIRSCAPE AI-Readiness Packaging: All datasets packaged using FAIRSCAPE framework which creates
      RO-Crate packages with datasets, metadata, provenance graphs, and software. FAIRSCAPE-CLI validates
      inputs and creates output RO-Crate packages. FAIRSCAPE server assigns persistent resolvable globally
      unique identifiers (ARK scheme with DOIs as supplementary PIDs for final-state publishable work),
      decomposes RO-Crates into components, and computes end-to-end provenance entailments using EVI
      Evidence Graph Ontology.
  - id: cleaning-002
    description: >
      Data Standard Mapping: Data mapped to applicable standards and ontologies including Gene Ontology
      (GO), Reactome, Protein Data Bank (PDB), AlphaFold Protein Structure Database, Schema.org, and EVI
      Evidence Graph Ontology. Keywords mapped to controlled vocabularies from NCI Thesaurus, BioAssay
      Ontology, Cell Ontology, CHEBI, Experimental Factor Ontology, and other ontologies.
  - id: cleaning-003
    description: >
      Integrative Structure Modeling Annotation: Bioinformatics pipeline developed for annotating MuSIC
      communities with available structural information from PDB, AlphaFoldDB, crosslinking mass
      spectrometry, and prediction of disordered sequence segments. Communities ranked by structural
      information amount as proxy for integrative modeling feasibility. Integrative structure modeling
      performed using Python Modeling Interface and Integrative Modeling Platform (IMP) version 2.18.

# Uses
intended_uses:
  - id: use-001
    description: >
      AI Model Training for Functional Genomics: Primary intended use is training and development of
      artificial intelligence and machine learning models for functional genomics research. AI-ready
      datasets with full provenance, metadata, and validation enable immediate use in AI/ML pipelines
      without reformatting.
  - id: use-002
    description: >
      Visible Neural Network Development: Development of visible neural networks (VNNs) that use hierarchical
      cell maps as interpretable model architectures. Unlike black box models, VNNs built on cell maps
      allow interrogation of how protein assemblies affect cell-level phenotypes, enabling interpretation
      of genetic variants and mutations in the context of cellular mechanisms.
  - id: use-003
    description: >
      Genotype-Phenotype Mapping Research: Research into interpretable genotype-phenotype learning using
      multi-scale cell maps. Enables understanding of mechanisms by which genotypes translate to phenotypes,
      supporting precision medicine applications.
  - id: use-004
    description: >
      Cellular Process Analysis: Analysis of cell architectural changes and interactions in presence of
      specific disease processes, treatment conditions, or genetic perturbations. Suitable for
      bioinformatics analysis requiring domain expertise.

prohibited_uses:
  - id: prohibited-001
    description: >
      Clinical Decision-Making: Laboratory data are not to be used in clinical decision-making or in any
      context involving patient care without appropriate regulatory oversight and approval. This is
      research data from cell lines, not clinical diagnostic data.

# Distribution
distribution_formats:
  - id: format-001
    name: University of Virginia Dataverse - RO-Crate Packages
    description: >
      Primary distribution through LibraData, University of Virginia's Dataverse instance (an NIH-approved
      generalist repository). All output data packaged as Research Object Crates (RO-Crate version 1.2)
      using FAIRSCAPE framework. RO-Crates contain datasets, metadata, provenance graphs, and software
      with resolvable references. Metadata expressed in JSON-LD graph language using vocabularies from
      Schema.org, EVI Evidence Graph Ontology, and other well-defined public ontologies. Data releases
      available with DOI 10.18130/V3/DXWOS5 (March 2025) and DOI 10.18130/V3/F3TD5R (June 2025). Quarterly
      updates planned through November 2026.
    access_urls:
      - https://doi.org/10.18130/V3/DXWOS5
      - https://doi.org/10.18130/V3/F3TD5R
      - https://dataverse.lib.virginia.edu/
  - id: format-002
    name: Immunofluorescence Imaging Data - ZIP Archives
    description: >
      Immunofluorescence images in standard confocal microscopy formats distributed as ZIP archives
      (2.6-4.6 GB per condition). RGB immunofluorescent images included in June 2025 release. Four-channel
      imaging data with DAPI (nuclei), calreticulin (ER), tubulin (microtubules), and protein-of-interest
      antibodies. Spatial localization of 464-563 proteins in MDA-MB-468 cells under three treatment
      conditions.
    access_urls:
      - https://dataverse.lib.virginia.edu/
  - id: format-003
    name: Mass Spectrometry Data - MassIVE Repository
    description: >
      AP-MS and SEC-MS data in standard mass spectrometry data formats suitable for deposition to MassIVE
      Repository. Includes raw data and processed interaction networks for both human iPSCs and cancer
      cells. Data available with persistent identifiers for reproducibility.
    access_urls:
      - https://massive.ucsd.edu/
  - id: format-004
    name: CRISPR Perturbation Screens - NCBI SRA
    description: >
      Raw sequence data from CRISPR perturbation screens in FASTQ format deposited to NCBI BioProject
      and Sequence Read Archive (SRA) for long-term archival and public access. Processed cell atlas
      data in RO-Crate format with JSON metadata.
    access_urls:
      - https://www.ncbi.nlm.nih.gov/bioproject/
      - https://www.ncbi.nlm.nih.gov/sra/
  - id: format-005
    name: Hierarchical Cell Maps - NDEx
    description: >
      Hierarchical cell maps as directed acyclic graphs (DAG) compatible with Cytoscape, HiView, and NDEx.
      Cell maps shared via Network Data Exchange (NDEx) and can be visualized in a web browser or accessed
      via tools such as Cytoscape, HiView, and the Python ndex2 library. Includes JSON-Schema data
      dictionaries for all datasets.
    access_urls:
      - https://www.ndexbio.org/
  - id: format-006
    name: CM4AI Web Portal
    description: >
      Open dissemination of CM4AI-generated data, maps, and tools via the CM4AI web portal using the
      U-BRITE platform to support open and trustworthy data management and sharing. CodeFest event
      materials and tutorials available.
    access_urls:
      - http://www.cm4ai.org

# Maintenance
updates:
  id: updates-001
  name: Quarterly Data Releases and Augmentation
  description: >
    Dataset regularly updated and augmented through the end of the project in November 2026. Updates on
    a quarterly basis. Current releases are interim beta releases with some datasets under temporary
    pre-publication embargo. Computed cell maps will be added in future releases. Dataset versioned with
    major and minor releases tracked in Dataverse. March 2025 release (V1) and June 2025 release (V2)
    with corrections to ro-crate metadata and naming conventions. All versions preserved with DOIs for
    reproducibility. Long-term preservation in the University of Virginia Dataverse, supported by
    committed institutional funds.
  frequency: Quarterly updates through November 2026
  update_details:
    - Quarterly data releases with version tracking
    - March 2025 release (V1) - Initial beta release
    - June 2025 release (V2) - Corrections and RGB images
    - Computed cell maps planned for future releases
    - All versions preserved with persistent DOIs

maintainers:
  - id: maintainer-001
    name: CM4AI Consortium
    description: >
      Multi-institutional consortium managing dataset maintenance including University of California
      San Diego (lead institution), Stanford University (spatial proteomics), University of California
      San Francisco (protein-protein interactions), University of Virginia (standards and infrastructure),
      and Yale University (skills development).
    maintainer_details:
      - UCSD - Project leadership and data integration
      - Stanford - Spatial proteomics imaging
      - UCSF - Mass spectrometry PPI data
      - UVA - Standards module and Dataverse hosting
      - Yale - Workforce development
  - id: maintainer-002
    name: Data Governance Committee
    description: >
      Supervised by Data Access Committee for ethical matters related to dataset distribution and
      potential dual licensing for commercial use. Contact: Jillian Parker (jillianparker@health.ucsd.edu).
      Ethical review by Vardit Ravitsky (ravitskyv@thehastingscenter.org) and Jean-Christophe Belisle-Pipon
      (jean-christophe_belisle-pipon@sfu.ca).
    maintainer_details:
      - Data Access Committee oversight
      - Contact - jillianparker@health.ucsd.edu
      - Ethics review - ravitskyv@thehastingscenter.org
      - Ethics review - jean-christophe_belisle-pipon@sfu.ca

# Human Subjects Information
human_subject_research:
  id: hsr-001
  name: CM4AI Non-Clinical Cell Line Data
  description: >
    CM4AI data are distinctive within Bridge2AI in that they are non-clinical (from tissue cultures)
    and are considered to be de-identified as they cannot be matched, with current knowledge, to a human
    subject. Data derived from commercially available de-identified human cell lines: MDA-MB-468 breast
    cancer cells (ATCC, RRID:CVCL_0419) and KOLF2.1J induced pluripotent stem cells (HipSci,
    RRID:CVCL_B5P3). No direct human subjects research. FDA Regulated: No. Ethically sourced cell lines
    with appropriate material transfer agreements. Ethics team employs Value-Sensitive Design (VSD)
    methodology, CM4AI Life Cycle framework, and mixed empirical research to ensure responsible design
    of datasets and AI technologies.
  involves_human_subjects: false
  ethics_review_board:
    - Data Access Committee for ethical oversight
    - Ethics team (Vardit Ravitsky, Jean-Christophe Belisle-Pipon)
    - Value-Sensitive Design methodology framework
    - CM4AI Life Cycle governance framework

sensitive_elements:
  - id: sensitive-001
    name: De-identified Cell Line Data
    description: >
      Data derived from commercially available de-identified human cell lines. While cell lines are
      considered de-identified and cannot be matched to human subjects with current knowledge, ethical
      considerations are embedded throughout data generation and AI system development. Ethics team
      develops tools for enhancing awareness of ethical, legal, and social ramifications. Mixed empirical
      research combines qualitative and quantitative methods to capture community insights for guidelines
      and best practices.
    sensitive_elements_present: false
    sensitivity_details:
      - De-identified cell lines (MDA-MB-468, KOLF2.1J)
      - No patient-identifiable information
      - Commercially available with MTAs
      - Ethically sourced from ATCC and HipSci
      - Value-Sensitive Design framework applied
      - Axiological repository of values for design standards

# Data Governance and Licensing
license: CC BY-NC-SA 4.0

license_and_use_terms:
  id: license-001
  name: Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International
  description: >
    Dataset licensed for reuse under CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).
    Attribution is required to the copyright holders and the authors. Data are Copyright (c) 2025 The
    Regents of the University of California except where otherwise noted. Spatial proteomics raw image
    data is copyright (c) 2025 The Board of Trustees of the Leland Stanford Junior University. Commercial
    use of data requires a separate license negotiation with the copyright holder (UCSD, Stanford, and/or
    UCSF depending upon the specific data package in question). A Data Access Committee will supervise
    ethical matters related to dataset distribution and potential dual licensing for commercial use. All
    CM4AI integration and packaging software is freely available and licensed under nonrestrictive
    open-source licenses (FAIRSCAPE: MIT License, MuSIC: BSD-3 License, IMP: open source). No regulatory
    restrictions apply. Data derived from commercially available de-identified human cell lines. No human
    subjects research. No FDA regulation applicable. No export control restrictions.
  license_terms:
    - CC BY-NC-SA 4.0 license for dataset
    - Attribution required to copyright holders and authors
    - Copyright 2025 Regents of University of California (UCSD)
    - Spatial proteomics copyright 2025 Stanford University
    - Commercial use requires separate license negotiation
    - Contact UCSD, Stanford, or UCSF for commercial licensing
    - Data Access Committee supervises dual licensing
    - Citation required - Clark T, Parker J, et al. BioRxiv 2024 DOI 10.1101/2024.05.21.589311
    - Software under open source licenses (MIT, BSD-3)
    - No regulatory restrictions or export controls
    - No FDA regulation applicable
    - Ethically sourced de-identified cell lines

retention_limit:
  id: retention-001
  name: Long-term Preservation in UVA Dataverse
  description: >
    Long-term preservation in the University of Virginia Dataverse, supported by committed institutional
    funds. All dataset versions preserved with persistent DOIs for reproducibility. No planned deletion
    or retention limits. Quarterly updates through November 2026, with final release preserved indefinitely.
  retention_details:
    - Indefinite preservation in UVA Dataverse
    - Committed institutional funding for long-term hosting
    - All versions preserved with persistent DOIs
    - No planned deletion or data expiration
    - Quarterly updates through project end (November 2026)
